The global endoscopic vessel harvesting (EVH) system market is estimated to be worth USD 577.1 million in 2025 and is projected to reach USD 949 million by 2035, expanding at a steady CAGR of 5.1%.
The United States and Germany remain the dominant markets due to high volumes of coronary artery bypass grafting (CABG) procedures and advanced healthcare infrastructure, while countries like Japan and India are rapidly catching up due to growing cardiac disease prevalence and adoption of minimally invasive techniques. Among vessel types, saphenous vein harvesting continues to dominate procedures, while disposable EVH systems are preferred globally due to sterility and ease of use.
The primary growth drivers include the rising incidence of cardiovascular diseases, especially ischemic heart conditions, and a corresponding increase in surgical interventions like CABG. EVH systems have gained traction for their ability to reduce surgical trauma, lower infection rates, and improve recovery outcomes.
Hospitals are favoring these systems for their efficiency and patient safety advantages over open vessel harvesting techniques. Moreover, the emergence of robot-assisted EVH systems, better endoscopic visualization, and AI-enabled imaging tools are enhancing procedural success and surgeon confidence.
Despite the strong outlook, the market faces certain challenges. High device costs, lengthy surgeon training requirements, and uneven regulatory pathways in emerging markets hinder faster adoption. Additionally, concerns regarding vessel quality and long-term graft patency continue to be evaluated. However, these concerns are increasingly addressed through innovations in endoscopic precision, surgeon training platforms, and bioengineered graft alternatives.
Looking ahead, the market is expected to be shaped by AI-integrated harvesting, telemedicine-based training programs, and biodegradable surgical components that support value-based care. Strategic partnerships between hospitals and device manufacturers, along with regional production hubs, will play a crucial role in making EVH systems more accessible, affordable, and sustainable-especially in Asia-Pacific and Latin America.
Disposable EVH systems are expected to remain dominant throughout the forecast period, primarily due to their ease of use, reduced cross-contamination risk, and compatibility with hospital infection control protocols. As cardiovascular surgeries like CABG rise globally, hospitals prefer single-use systems to eliminate the complexities of reprocessing and sterilization, especially in high-volume surgical settings. The shift toward single-use devices is more evident in the USA, Europe, and advanced Asian hospitals, where procedural consistency and infection minimization are top priorities.
Meanwhile, reusable EVH systems are gaining traction in cost-sensitive markets like India, Brazil, and parts of Southeast Asia, where long-term value and sustainability are key considerations. Technological advancements in durability and sterilization compatibility will gradually improve reusable system uptake.
| Product Type | CAGR (2025 to 2035) |
|---|---|
| Disposable EVH Systems | 5.5% |
The saphenous vein remains the most harvested vessel type in CABG procedures due to its accessibility, length, and compatibility. EVH techniques have revolutionized saphenous vein harvesting by reducing trauma and infection, resulting in shorter hospital stays and faster recovery. With growing confidence in minimally invasive harvesting, hospitals are increasingly favoring EVH over open procedures.
The radial artery is gaining preference in younger patients due to its higher patency rates but still remains secondary due to patient selection limitations and procedural complexity. Continuous improvements in endoscopic imaging and electrocautery tools will sustain dominance of the saphenous vein segment.
| Vessel Type | CAGR (2025 to 2035) |
|---|---|
| Saphenous Vein | 5.2% |
Coronary artery bypass grafting (CABG) remains the primary driver for EVH system adoption. With ischemic heart disease on the rise, especially in aging populations across the USA, Europe, Japan, and now India and China, the demand for minimally invasive, high-precision harvesting systems has accelerated.
CABG surgeries require multiple high-quality conduits, and EVH systems deliver improved outcomes by ensuring graft integrity while minimizing operative trauma. Peripheral artery disease (PAD) and other cardiovascular surgeries are emerging applications but will remain niche over the forecast period.
| Application | CAGR (2025 to 2035) |
|---|---|
| Coronary Artery Bypass Grafting (CABG) | 5.4% |
Challenges
The not so familiar with electronic vessel harvesters (EVH), the long time required for training and a lack of awareness of the market in some regions may be the main barriers against sales and executive acceleration.
Furthermore, lack of confidence in the very long term survival of vessel collection and the risk of using it incorrectly can be some of the factors affecting the approval of the technology. Regulations that are tough and the slow approval process of some EVH systems in clinical settings can inhibit the wide adoption of the new technology.
Opportunities
Endoscopic imaging technology getting better, strongly present AI-enabled surgical devices, and even hybrids of surgery. These three are the best outcomes for business growth. Telemedicine and virtual CV surgeon training programs are showing improvement in the area of EVH.
Other than that, the linkages between hospitals and medical device manufacturers to develop economically friendly products are projected to be a catalyst feasible for both of them. Bioengineering of grafts and using analytics through AI for real-time intraoperative assistance are also showing signs of changes in the future technology of EVH.
The period from 2020 to 2024 saw the EVH market expanding on a continual basis with all the cardiovascular diseases due to the incessant increase in the number of CABG surgeries and developments in minimally invasive surgery.
The mandate for EVH was largely owed to the fact that it brought along with it way less surgical trauma, decreased wrong infection factors, and people got hospital all the faster right back home. On the contrary, the bright side was rather the advantages of the EVH approach-the EVH system by the fact that it was more minimally invasive than the traditional open vessels surgery, less trauma was inflicted on the patient, the risk of infections was lower and the recovery period was faster.
Nonetheless, the reluctance to its adoption was due to a number of concerns, like the high cost of EVH systems, the necessity of advanced surgical skills, and the variance of procedure outcomes.
In the period before 2025 to 2035, technology will be the main player in influencing the market by bringing to life such technologies as AI-powered harvesting techniques, robot-assisted EVH systems, and upgraded endoscopic equipment. The regulatory bodies will have the responsibility of post-market surveillance and thereby intensify procedural safety and long-term graft patency.
The trend to value-based care will determine savings; for example, the use of disposable and ergonomic EVH systems will be cost-saving while on the part of hospitals, green surgical components will be the best choice among different similar equipment.
Market Outlook
The United States endoscopic vessel harvesting (EVH) systems market is continuously growing due to the increasing lifestyle-related health problems, like cardiovascular diseases, and the growing demand for minimally invasive surgeries.
The use of these systems in the bypass surgery of the coronary arteries by blockage has become even more widespread as a result of the aforementioned factors, the procedure of which reduces the possibility of negative effects on the patient's surgical reaction and contributes its perfection to the patient's new life.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 2.1% |
Market Outlook
There is increasing optimism regarding the EVH systems market in Germany, mainly because of a promising healthcare system and good professional attention to advanced surgeries. The stressed management towards improvement in surgery results and quality patient care are conducive in using EVH systems in cardiovascular surgeries.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 3.8% |
Market Outlook
India's EVH systems market is an emerging industry which is driven by the rising burden of cardiovascular diseases and the growth of the healthcare infrastructure. The is gained of the adaption of the minimally invasive surgical techniques in urban medical centers to the market extension as well.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 3.9% |
Market Outlook
Japan's EVH systems market is extremely sophisticated owing to state-of-the-art medical developments and the healthcare system's emphasis on minimally invasive procedures. The country's aging population and high healthcare standards are the pivot that drives the preference of EVH systems for cardiac surgery in.
Market Growth Factors
Technological Innovation: Technology in the health sphere is developing constantly in Japan and all that is why the most up-to-date EVH machines are available on the market. Aging Demographics: A big AT INCREASE IN THE CARDIAC
Healthcare Quality Standards: Japan's strict compliance to the best medical practices is enabling the implementation of advanced surgical techniques.
Research and Development: The EVO, inevitably closely linked to the ongoing R&D procedures, also contributes to the blending and scoring of the EVH technologies of the future, are thoroughly explained in the rest of this book. Patient Outcomes Focus: The best practice involves introducing new minimally invasive procedures like EVH that, in turn, have the best patient outcomes.
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 4.6% |
Market Outlook
The market for EVH systems in Brazil is increasing, sustained by healthcare improvements and rising awareness of minimally invasive surgical options. The growing incidence of cardiovascular diseases calls for effective surgical management and impels the acceptance of EVH systems.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Brazil | 3.5% |
Endoscopic vessel harvesting (EVH) systems haunt the market with the competition raging from top players worldwide and from domestic players. They grow increasingly with the rise in the prevalence of cardiovascular diseases, advances in minimally invasive surgical approaches, increased consumer preference for procedures that minimize rehabilitation time and complications, and increased need for technology adoption in EVH.
Firms find the ground to invest in precision engineering, automation, and the better ergonomics of the users. Established manufacturers and up-rising brands will both contribute to the ever-changing landscape of EVH technology in the continuous dynamic industry.
Getinge AB (24.6%)
A market leader in EVH, Getinge AB is known for its Vasoview Hemopro series, which makes use of simultaneous cut-and-seal technology to enhance conduit quality and minimize thermal injury during vessel harvesting.
Terumo Corporation (18.5%)
Terumo VirtuoSaph Plus EVH system is engineered to be easy to use with an ergonomic design that supports minimally invasive vessel harvesting, thus improving patient outcomes.
LivaNova PLC (13.5%)
LivaNova concentrates on designing EVH solutions that emphasize ergonomics for the surgeon and procedural efficiency, which leads to enhanced recovery for patients undergoing CABG surgery.
KARL STORZ SE & Co. (9.6%)
Renowned for precision engineering, KARL STORZ offers endoscopes and accessories that enable vessel harvesting with proficiency and durability alongside surgical performance.
Saphena Medical Inc. (7.5%)
Saphena Medical provides unitary EVH systems intended to simplify the harvesting procedure with the goal of decreasing operative time and improving patient recovery.
Beyond the leading companies, several other manufacturers contribute significantly to the market, enhancing product diversity and technological advancements. These include:
| Report Attributes | Details |
|---|---|
| Estimated Market Size (2025) | USD 577.1 million |
| Projected Market Size (2035) | USD 949 million |
| CAGR | 5.1% CAGR |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Forecast Period | 2025 to 2035 |
| Report Parameter | Revenue in USD million |
| Product Types Analyzed | Disposable EVH Systems, Reusable EVH Systems |
| Vessel Types Covered | Saphenous Vein, Radial Artery, Others |
| Applications Analyzed | Coronary Artery Bypass Grafting (CABG), Peripheral Artery Disease (PAD) |
| End Use Industries | Hospitals, Ambulatory Surgical Centers, Specialty Clinics |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia, Middle East & Africa |
| Countries Covered | United States, Japan, Germany, India, United Kingdom, France, Italy, Brazil, Canada, South Korea, Australia, Spain, Netherlands, Saudi Arabia, Switzerland |
| Top Segments Covered | By Product Type, By Application, By End Use |
| Top Growth Markets | Asia Pacific, Latin America |
| Key Players | Getinge AB, Terumo Corporation, Med Europe S.r.l., Saphena Medical, LivaNova PLC, Cardio Medical GmbH |
| Additional Attributes | Minimally invasive surgery trends, Cost-benefit analysis of reusable vs disposable, Regional regulatory insights |
| Customization & Pricing | Available upon request |
The global endoscopic vessel harvesting system industry is projected to witness CAGR of 5.1% between 2025 and 2035.
The global Endoscopic Vessel Harvesting System industry stood at USD 552.24 million in 2024.
The global rare neurological disease treatment industry is anticipated to reach USD 949 million by 2035 end.
China is expected to show a CAGR of 4.6% in the assessment period.
The key players operating in the global endoscopic vessel harvesting system industry are Getinge AB, Terumo Corporation, LivaNova PLC, KARL STORZ SE & Co., Saphena Medical Inc. and Other market players.
Explore Therapeutic Device Insights
Endoscopic Vessel Harvesting System Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
